Literature DB >> 16769857

Use of higher medication concentrations in the treatment of acanthamoeba keratitis.

William Mathers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16769857     DOI： 10.1001/archopht.124.6.923

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  8 in total

1.  Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.

Authors:  Zubeyde Akin Polat; Ayse Vural
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.

Authors:  Elmer Y Tu; Charlotte E Joslin; Megan E Shoff
Journal:  Cornea       Date:  2010-09       Impact factor: 2.651

3.  Practice patterns and opinions in the treatment of acanthamoeba keratitis.

Authors:  Catherine E Oldenburg; Nisha R Acharya; Elmer Y Tu; Michael E Zegans; Mark J Mannis; Bruce D Gaynor; John P Whitcher; Thomas M Lietman; Jeremy D Keenan
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

4.  Double-biguanide therapy for resistant acanthamoeba keratitis.

Authors:  Giulio Ferrari; Stanislav Matuska; Paolo Rama
Journal:  Case Rep Ophthalmol       Date:  2011-11-05

5.  Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis.

Authors:  Firoozeh Rahimi; Seyed Mohammad Nasser Hashemian; Mohammadreza Falah Tafti; Mohammadali Zare Mehjerdi; Mona Seyed Safizadeh; Elias Khalili Pour; Bahram Bohrani Sefidan
Journal:  J Ophthalmic Vis Res       Date:  2015 Apr-Jun

Review 6.  Non-contact lens related Acanthamoeba keratitis.

Authors:  Prashant Garg; Paavan Kalra; Joveeta Joseph
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

7.  The Effect of Anti-Amoebic Agents and Ce6-PDT on Acanthamoeba castellanii Trophozoites and Cysts, In Vitro.

Authors:  Lei Shi; Vithusan Muthukumar; Tanja Stachon; Lorenz Latta; Mohamed Ibrahem Elhawy; Gubesh Gunaratnam; Erika Orosz; Berthold Seitz; Albrecht F Kiderlen; Markus Bischoff; Nóra Szentmáry
Journal:  Transl Vis Sci Technol       Date:  2020-11-23       Impact factor: 3.283

8.  Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.

Authors:  Jeremy J Hoffman; Reena Yadav; Sandip D Sanyam; Pankaj Chaudhary; Abhishek Roshan; Sanjay K Singh; Sanjay K Singh; Sailesh K Mishra; Simon Arunga; Victor H Hu; David Macleod; Astrid Leck; Matthew J Burton
Journal:  Ophthalmology       Date:  2021-12-09       Impact factor: 14.277
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.